Canada markets close in 3 hours 8 minutes

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.47-0.32 (-1.54%)
As of 12:52PM EDT. Market open.
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
295,394
74,356
221,965
115,243
Other Short Term Investments
282,189
410,041
224,865
177,822
Total Cash
577,583
484,397
446,830
293,065
Net Receivables
0
3,474
0
-
Other Current Assets
63
117
150
341
Total Current Assets
580,876
489,786
448,396
298,864
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,906
1,458
1,704
881
Accumulated Depreciation
-411
-399
-443
-399
Net property, plant and equipment
1,495
1,059
1,261
482
Equity and other investments
29,829
5,469
0
-
Other long-term assets
680
922
-
1,267
Total non-current assets
32,004
7,450
1,261
1,749
Total Assets
612,880
497,236
449,657
300,613
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
-
-
-
2,285
Accounts Payable
17,193
4,350
5,669
3,508
Accrued liabilities
27,796
17,727
8,422
7,505
Deferred revenues
-
-
0
1,517
Other Current Liabilities
888
604
1,888
528
Total Current Liabilities
58,096
29,065
20,683
18,872
Non-current liabilities
Long Term Debt
-
-
19,895
17,834
Deferred revenues
-
-
0
11,617
Other long-term liabilities
-
-
-
1
Total non-current liabilities
588
722
20,606
29,553
Total Liabilities
58,684
29,787
41,289
48,425
Stockholders' Equity
Common Stock
8
7
6
5
Retained Earnings
-902,400
-693,040
-543,702
-568,628
Accumulated other comprehensive income
218
-806
45
-4
Total stockholders' equity
554,196
467,449
408,368
252,188
Total liabilities and stockholders' equity
612,880
497,236
449,657
300,613